ORBIMED ADVISORS LLC 13D and 13G filings for Compass Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-22 4:59 pm Unchanged | 2024-03-21 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 18,791,422 13.700% | 0 (Unchanged) | Filing |
| 2022-11-10 4:25 pm Purchase | 2022-11-08 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 18,791,422 14.900% | 719,875 (+3.98%) | Filing |
| 2021-11-09 5:30 pm Purchase | 2021-11-04 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 18,071,547 18.400% | 5,357,143 (+42.13%) | Filing |
| 2021-07-14 5:08 pm Purchase | 2021-07-09 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 12,714,404 20.400% | 12,714,404 (New Position) | Filing |